✦ LIBER ✦

Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: A randomized phase 2 trial

✍ Scribed by G. Romieu; M. Clemens; R. Mahlberg; P. Fargeot; M. Constenla; M. Schütte; V. Easton; T. Skacel; P. Bacon; W. Brugger

Book ID: 108110097
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 145 KB
Volume: 64
Category: Article
ISSN: 1040-8428
DOI: 10.1016/j.critrevonc.2006.12.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 randomized trial of primary endo

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer

✍ Vladimir F. Semiglazov; Vladislav V. Semiglazov; Garik A. Dashyan; Elena K. Zilt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Abstract ## BACKGROUND. Few studies have compared primary neoadjuvant endocrine therapy with neoadjuvant chemotherapy in breast cancer patients. The need for preoperative chemotherapy with doxorubicin or taxanes may be reduced in postmenopausal patients with estrogen receptor (ER)‐positive and/

Randomized trial of low-dose interleukin

Randomized trial of low-dose interleukin-2 vs cyclosporine A and interferon-γ after high-dose chemotherapy with peripheral blood progenitor support in women with high-risk primary breast cancer

✍ Vahdat, L T; Cohen, D J; Zipin, D; Lo, K S; Donovan, D; Savage, D; Tiersten, A; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 155 KB

A randomized phase III comparative trial

A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy

✍ Vredenburgh, J J; Madan, B; Coniglio, D; Ross, M; Broadwater, G; Niedzwiecki, D; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 141 KB